Cargando…
Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway
Polypharmacy is associated with poorer health outcomes in older adults. It is challenging to minimize the harmful effects of medications while maximizing benefits of single-disease-focused recommendations. Integrating patient input can balance these factors. The objectives are to describe the goals,...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196540/ https://www.ncbi.nlm.nih.gov/pubmed/37213440 http://dx.doi.org/10.1177/23743735231174762 |
_version_ | 1785044378119569408 |
---|---|
author | Mangin, Dee Lamarche, Larkin Freeman, Karla Ali, Abbas Clark, Rebecca Shah, Nikki Awan, Amen Langevin, Jessica Parascandalo, Jenna Dore Brown, Naomi Jurcic-Vrataric, Jane Colwill, Kiska Dragos, Steven Borhan, Sayem Risdon, Cathy Siu, Henry Farrell, Barbara Trimble, Johanna |
author_facet | Mangin, Dee Lamarche, Larkin Freeman, Karla Ali, Abbas Clark, Rebecca Shah, Nikki Awan, Amen Langevin, Jessica Parascandalo, Jenna Dore Brown, Naomi Jurcic-Vrataric, Jane Colwill, Kiska Dragos, Steven Borhan, Sayem Risdon, Cathy Siu, Henry Farrell, Barbara Trimble, Johanna |
author_sort | Mangin, Dee |
collection | PubMed |
description | Polypharmacy is associated with poorer health outcomes in older adults. It is challenging to minimize the harmful effects of medications while maximizing benefits of single-disease-focused recommendations. Integrating patient input can balance these factors. The objectives are to describe the goals, priorities, and preferences of participants asked about these in a structured process to polypharmacy, and to describe the extent that decision-making within the process mapped onto these, signaling a patient-centered approach. This is a single-group quasi-experimental study, nested within a feasibility randomized controlled trial. Patient goals and priorities were mapped to medication recommendations made during the intervention. Overall, there were 33 participants who reported 55 functional goals and 66 symptom priorities, and 16 participants reported unwanted medications. Overall, 154 recommendations for medication alterations occurred. Of those, 68 (44%) recommendations mapped to the individual's goals and priorities, whereas the rest were based on clinical judgment where no priorities were expressed. Our results signal this process supports a patient-centered approach: allowing conversations around goals and priorities in a structured process to polypharmacy should be integrated into subsequent medication decisions. |
format | Online Article Text |
id | pubmed-10196540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-101965402023-05-20 Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway Mangin, Dee Lamarche, Larkin Freeman, Karla Ali, Abbas Clark, Rebecca Shah, Nikki Awan, Amen Langevin, Jessica Parascandalo, Jenna Dore Brown, Naomi Jurcic-Vrataric, Jane Colwill, Kiska Dragos, Steven Borhan, Sayem Risdon, Cathy Siu, Henry Farrell, Barbara Trimble, Johanna J Patient Exp Research Article Polypharmacy is associated with poorer health outcomes in older adults. It is challenging to minimize the harmful effects of medications while maximizing benefits of single-disease-focused recommendations. Integrating patient input can balance these factors. The objectives are to describe the goals, priorities, and preferences of participants asked about these in a structured process to polypharmacy, and to describe the extent that decision-making within the process mapped onto these, signaling a patient-centered approach. This is a single-group quasi-experimental study, nested within a feasibility randomized controlled trial. Patient goals and priorities were mapped to medication recommendations made during the intervention. Overall, there were 33 participants who reported 55 functional goals and 66 symptom priorities, and 16 participants reported unwanted medications. Overall, 154 recommendations for medication alterations occurred. Of those, 68 (44%) recommendations mapped to the individual's goals and priorities, whereas the rest were based on clinical judgment where no priorities were expressed. Our results signal this process supports a patient-centered approach: allowing conversations around goals and priorities in a structured process to polypharmacy should be integrated into subsequent medication decisions. SAGE Publications 2023-05-17 /pmc/articles/PMC10196540/ /pubmed/37213440 http://dx.doi.org/10.1177/23743735231174762 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Article Mangin, Dee Lamarche, Larkin Freeman, Karla Ali, Abbas Clark, Rebecca Shah, Nikki Awan, Amen Langevin, Jessica Parascandalo, Jenna Dore Brown, Naomi Jurcic-Vrataric, Jane Colwill, Kiska Dragos, Steven Borhan, Sayem Risdon, Cathy Siu, Henry Farrell, Barbara Trimble, Johanna Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway |
title | Linking Patients’ Goals and Priorities to Recommendations for
Medication Changes in a Polypharmacy-Focused Structured Clinical
Pathway |
title_full | Linking Patients’ Goals and Priorities to Recommendations for
Medication Changes in a Polypharmacy-Focused Structured Clinical
Pathway |
title_fullStr | Linking Patients’ Goals and Priorities to Recommendations for
Medication Changes in a Polypharmacy-Focused Structured Clinical
Pathway |
title_full_unstemmed | Linking Patients’ Goals and Priorities to Recommendations for
Medication Changes in a Polypharmacy-Focused Structured Clinical
Pathway |
title_short | Linking Patients’ Goals and Priorities to Recommendations for
Medication Changes in a Polypharmacy-Focused Structured Clinical
Pathway |
title_sort | linking patients’ goals and priorities to recommendations for
medication changes in a polypharmacy-focused structured clinical
pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196540/ https://www.ncbi.nlm.nih.gov/pubmed/37213440 http://dx.doi.org/10.1177/23743735231174762 |
work_keys_str_mv | AT mangindee linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT lamarchelarkin linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT freemankarla linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT aliabbas linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT clarkrebecca linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT shahnikki linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT awanamen linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT langevinjessica linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT parascandalojenna linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT dorebrownnaomi linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT jurcicvrataricjane linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT colwillkiska linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT dragossteven linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT borhansayem linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT risdoncathy linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT siuhenry linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT farrellbarbara linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway AT trimblejohanna linkingpatientsgoalsandprioritiestorecommendationsformedicationchangesinapolypharmacyfocusedstructuredclinicalpathway |